4.6 Article

Lipidomics analysis based on liquid chromatography mass spectrometry for hepatocellular carcinoma and intrahepatic cholangiocarcinoma

期刊

RSC ADVANCES
卷 5, 期 78, 页码 63711-63718

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c5ra09589a

关键词

-

资金

  1. Key Program of Natural Science Foundation of State [81470196, 81302905]
  2. Natural Science Foundation of Heilongjiang Province of China [H2015038]

向作者/读者索取更多资源

Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) account for nearly all primary liver cancers. Diagnosis of ICC and HCC still remains a challenge because of the lack of sensitive diagnostic and sufficiently accurate tests. Lipidomics is a critical part of metabolomics and aims to study all the lipids within a living system. In order to have a better and noninvasive diagnostic test, we profiled the lipidomics in a total of 292 blood samples from patients and normal individuals. It revealed that four metabolites, PE(19 : 0/0 : 0), PE(18 : 2(9Z,12Z)/0 : 0), PC(14 : 0/0 : 0) and PC(18 : 0/0 : 0), were defined as marker metabolites, which can be used to distinguish the HCC and ICC. Discrimination analysis showed that a combination of these metabolites could be used as markers for HCC and ICC with better diagnostic parameters with high sensitivity and specificity than using a single metabolite marker. Lipidomic profiling could allow us to predict the disease in its early stages.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据